Disparate immune receptor control by p53 sufficient and p53 deficient cancers.
Fuente:
Zenodo
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Recurso digital |
| Veröffentlicht: |
Zenodo
2026
|
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866901540435918848 |
|---|---|
| author | Mamoor, Shahan |
| author_facet | Mamoor, Shahan |
| contents | <p>We used an isogenic PDX model of human triple negative breast cancer in p53 wild-type and p53 deficient backgrounds for discovery of immunologic change resulting from or associated with p53 status in cancer. </p> <p> </p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20128295 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Disparate immune receptor control by p53 sufficient and p53 deficient cancers. Mamoor, Shahan <p>We used an isogenic PDX model of human triple negative breast cancer in p53 wild-type and p53 deficient backgrounds for discovery of immunologic change resulting from or associated with p53 status in cancer. </p> <p> </p> |
| title | Disparate immune receptor control by p53 sufficient and p53 deficient cancers. |
| url | https://doi.org/10.5281/zenodo.20128295 |